These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure. Hashimoto K; Yabuuchi Y; Yamashita S; Mori T Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure. Sannia L; Ibba GV; Castellaccio M; Dore L Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649 [TBL] [Abstract][Full Text] [Related]
47. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142 [TBL] [Abstract][Full Text] [Related]
48. Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure. Strain J; Grose R; Maskin CS; LeJemtel TH Am Heart J; 1985 Jul; 110(1 Pt 1):91-6. PubMed ID: 3160228 [TBL] [Abstract][Full Text] [Related]
49. [Usefulness of OPC-8212, an inotropic agent, in patients with chronic congestive heart failure--a multiple dose evaluation on its effect and arrhythmogenesis]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Oct; 36(10):1125-31. PubMed ID: 3247528 [No Abstract] [Full Text] [Related]
50. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients. Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076 [TBL] [Abstract][Full Text] [Related]
51. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930 [TBL] [Abstract][Full Text] [Related]
53. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
54. [Acute hemodynamic effects of alifedrine in patients with heart failure]. Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988 [TBL] [Abstract][Full Text] [Related]
55. Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure. Takatsu Y; Yui Y; Hattori R; Sakaguchi K; Susawa T; Yui N; Kawai C Jpn Circ J; 1987 Jun; 51(6):611-6. PubMed ID: 3312701 [TBL] [Abstract][Full Text] [Related]
56. Central and regional hemodynamic effects of flosequinan for congestive heart failure. Haas GJ; Binkley PF; Carpenter JA; Leier CV Am J Cardiol; 1989 Jun; 63(18):1354-9. PubMed ID: 2658526 [TBL] [Abstract][Full Text] [Related]
57. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation]. Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897 [TBL] [Abstract][Full Text] [Related]
58. Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in conscious and anesthetized dogs. Miyazaki S; Sasayama S; Nakamura Y; Kihara Y; Susawa T; Kawai C J Cardiovasc Pharmacol; 1986; 8(1):14-20. PubMed ID: 2419676 [TBL] [Abstract][Full Text] [Related]
59. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure. Robinson PJ; Lvoff R; Chong B; Barrett PA Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545 [TBL] [Abstract][Full Text] [Related]
60. Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure. Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Schaefer HG; Mueck W; Bornemann M; Pouleur H J Am Coll Cardiol; 1997 Dec; 30(7):1751-7. PubMed ID: 9385903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]